Загрузка...

A comparison of sotagliflozin therapy for diabetes mellitus between week 24 with week 52: A protocol for mixed treatment comparisons meta-analysis

BACKGROUND: According to the centers for disease control and prevention, 14% of American adults have diabetes – 10% know it, and more than 4% go undiagnosed. Sotagliflozin is a new type of diabetes drug This study is to compare the efficacy of Sotagliflozin therapy for Diabetes Mellitus (DM) between...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Medicine (Baltimore)
Главные авторы: Zhang, Nie, Gu, Zhi-Qun, Ding, Yun-Long, Yang, Liu, Chen, Mao-Bing, Zheng, Qi-Han
Формат: Artigo
Язык:Inglês
Опубликовано: Wolters Kluwer Health 2019
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6882651/
https://ncbi.nlm.nih.gov/pubmed/31764805
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000017976
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!